Sweetsound,What i like about the management of NCZ is that they are forward looking and not just sitting on their hands. Shareholders will be rewarded, if they are prepared to hang in and wait.
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%